2N Pharma are an international team of researchers, business people and partners who share the vision that patients with brain diseases must have at least as many applicable treatment options as, fo..

AdaptVac aims to accelerate the development of safe and efficacious therapeutic and prophylactic vaccines to treat and prevent specific cancers, infectious diseases and immunological disorders. Adap..

Adjutec Pharma’s vision is to develop and provide novel antibiotic resistance breakers in order to retain efficacy and facilitate reduced use of antibiotics. Its lead products are two β-lactamase in..

Akasi Pharma is focused on non-opioid therapeutics for diabetic peripheral neuropathic pain. Their drugs target somatostatin receptor 4, aiming to reduce neuronal pain safely and effectively, offeri..

Traditional approaches to bringing cell therapies to market have many challenges — from high-risk development and unpredictable manufacturing processes to unreliable income models. Alder Therapeutic..

Amplify Therapeutics is developing first-in-class, disease-modifying therapeutics for lysosomal Parkinson’s disease.

AnaCardio is developing novel drugs to treat heart failure. First in class Ca2+ sensitizing myotrope. AnaCardio has generated proof of concept with peptide X in HFrEF patients and has partnered with..

Antag, a biotech company that develops a first in class drug for the treatment of obese Type 2 diabetic patients. Existing weight reducing therapeutics have serious side-effects and are ineffective ..

Apoglyx devlops new therapeutic concepts for metabolic and inflammatory diseases with innovative and proprietary Aquaporin technology and has a first in class therapeutic for treatment of sepsis. A..

Asgard Therapeutics is a spin-off company from Lund University focusing on developing cancer immunotherapies based on cell fate reprogramming through its new TrojanDC technology. The innovative i..

Using antibody AMT-technology in combination with the body's own immune system to fight cancer cells.

Draupnir Bio is a Biotech company that develops effective first in class therapeutics utilizing glycans. Glycans are polymers that they play an essential role in a number of processes such as; metab..

Fuse Vectors are developing a novel, infinitely scalable, gene therapy manufacturing platform. Using this platform technology, Fuse Vectors aim to increase gene therapy manufacturing process speed, ..

Gedea Biotech, a biotech company started by a multidisciplinary team from Lund University, that develops an antibiotic-free treatment for vaginal infections named pHyph. pHyph can be used to treat v..

Gesynta Pharma is a biotech company developing treatments based on mPGES-1 inhibitor for microvascular diseases in chronic inflammatory disorders. Intravascular mPGES-1 inhibition has been shown to ..

Disruptive treatment of follicular occlusion disorders Develops potent, stable enzymes for topical application to treat dermatological conditions. Primary focus is on acne-like disorders such as A..

In2cure, a biotech company, develops new peptide-based therapeutics to prevent infections and control inflammation. As the problem of multidrug resistance (MDR) is growing rapidly, the possibility t..

Kiox Pharma are developing treatments for patients with severe and rare lung diseases. Their project will treat and prevent BOS in lung transplants patients. This can potentially improve lung functi..

Loma Therapeutics focuses on immunotherapies designed to treat and prevent HPV-related cancers. By selectively activating T-cells, their therapies aim to boost the body’s immune response against can..

MonTa Biosciences, a biotech company whose lead program is focused on a new anti-cancer treatment that activates and educates the immune system to recognize and eliminate metastatic disease. This pr..

Mycural's mission is to develop innovative cancer therapies for patients with aggressive, high-risk tumors, with a special focus on resistant and metastatic cancers primarily driven by the oncoprote..

The vanguard in cell and gene therapies for muscle disorders MyoPax is developing a method for the isolation and cultivation of regenerative muscle stem cells. This enables MyoPax to produce larg..

One-Carbon Therapeutics AB is tackling the most difficult to treat cancers, inflammation and autoimmune diseases by targeting the disease specific one-carbon metabolism pathway, representing a novel..

Pancryos is dedicated to developing a safe and cost-efficient cell therapy to improve the quality of life of millions of people suffering from insulin-dependent diabetes. Pancryos has established a ..

The new generation antimicrobial peptides The vision is to contribute in the constant battle against global infections in a eco-friendly way by developing new potent drugs based on the nature’s on ..

PreTT is transforming cancer treatment with advanced pretargeted radioligand therapies that surpass traditional methods. Our proprietary technology enhances radioimmunotherapy, using monoclonal anti..

ResoTher Pharma, a biotech company, develops novel therapeutics to resolve chronic inflammation. Chronic inflammation can have a negative impact on tissue and organs and has been linked to several d..

Sartar Therapeutics develops a new precision cancer treatment, SAR001, for soft tissue sarcomas specifically expressing the phosphodiesterase 3. SAR001 is based on drug reformulation and reposition..

Sortina Pharma develops small-molecule therapies that target sortilin, a key protein involved in cancer and neurodegenerative diseases. By modulating this pathway, they aim to create novel, precise ..

Stayble Therapeutics, a biotech company, develops a new treatment against discogenic chronic low back pain. Discogenic chronic low back pain is a widely spread health issue that currently can only b..

Curing blindness with regenerative cell therapies StemSight’s first target indication is limbal stem cell deficiency (LSCD), a severe rare disease of the cornea currently without valid treatment op..

STipe Therapeutics, an early stage biotech company develops cancer drugs that target intracellular protein-protein interactions, which are highlighted as major drivers of innate immunity. The compan..

Strike Pharma are aiming to use their Adaptable Drug Affinity Conjugate (ADACTM) technology to enable development of individualized immunotherapeutic treatments based on the genetic profile of each ..

Teitur develops novel therapeutics for treating or preventing neurodegenerative diseases. From the Sortilins family of receptors, Teitur has developed cyclic peptides with a unique potential for ad..

TetraKit Technologies is aiming to revolutionize the development and preparation of theranostic radiopharmaceuticals through the unique radiolabeling platform: TetraKit. This platform allows for un..

ToxoTech develops advanced botulinum toxin therapies targeting neuromuscular and neurological disorders. Their innovative approach aims to improve efficacy, safety, and precision, offering enhanced ..

Virothera Ltd, a biotech start-up, is developing discoveries by the founder in targeting advancement of immune cells by human homologues of virus immune modifiers. These aim to solve problems of reg..